II-VI Incorporated Reports Fiscal 2015 First Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
II-VI Incorporated Reports Fiscal 2015 First Quarter Earnings; EPS Increases 33% on Revenue Growth of 24% from the Year-Ago Quarter
  • Operating income increased 44% compared to Q1 FY14
  • Net earnings increased 27% compared to Q1 FY14

PITTSBURGH, Oct. 28, 2014 (GLOBE NEWSWIRE) -- II-VI Incorporated (Nasdaq: IIVI ) ("II-VI" or the "Company") today reported results for its first fiscal quarter ended September 30, 2014.

Francis J. Kramer, President and Chief Executive Officer said, "This quarter was a good step forward. Our results were driven by improvements from most of the product portfolio, including fiber, direct diode and CO 2 laser components. We expect to deliver improving results during the coming quarters as we continue identifying synergies, consolidating businesses, and decreasing costs to address end market challenges."

Below is a summary of the Company's key operating performance metrics.

  $ Millions, except per share amounts, % and basis points ("bps")
  (Unaudited)
           
  Three Months Ended % Increase (Decrease) from
  Sept 30, June 30, Sept 30, June 30, Sept 30,
  2014 2014 2013 2014 2013
           
Bookings $181.7 $193.3 $142.5 (6%) 28%
Revenues $185.8 $187.9 $150.0 (1%) 24%
Net Earnings $12.3 $12.7 $9.7 (3%) 27%
Diluted earnings per share $0.20 $0.20 $0.15 - 33%
           
Other Selected Financial Metrics          
Gross margin 36.5% 33.2% 37.5% 330 bps (100 bps)
Operating margin 10.4% 7.8% 9.0% 260 bps 140 bps
EBITDA margin 16.8% 15.6% 16.8% 120 bps 0 bps
Return on sales 6.6% 6.7% 6.5% (10 bps) 10 bps

Bookings are orders we expect to convert to revenues within the next twelve months.

As discussed below under "Use of Non-GAAP Financial Measures," the Company is presenting non-GAAP financial measures in this release. Investors should consider non-GAAP adjusted measures in addition to, and not as a substitute for, or superior to, financial performance measures prepared in accordance with generally accepted accounting principles ("GAAP"). Please refer to the attached schedules for the applicable GAAP to non-GAAP reconciliations.

Outlook

For the second fiscal quarter ending December 31, 2014, the Company currently forecasts revenues from continuing operations to range from $172 million to $180 million and earnings per share from continuing operations to range from $0.15 to $0.18 per share-diluted. Comparable results for the quarter ended December 31, 2013 were revenues from continuing operations of $171.8 million and earnings per share from continuing operations of $0.12. All financial performance measures included in these forecasts and their respective historical references were prepared in accordance with GAAP. As discussed in more detail below, actual results may differ from these forecasts due to various factors including, but not limited to, changes in product demand, competition and general economic conditions.

Segment Simplification

As of July 1, 2014, the Company has realigned from five to three reporting segments and now reports its financial results as follows: (i) II‐VI Laser Solutions, (ii) II‐VI Photonics, and (iii) II‐VI Performance Products. Segment information for all periods presented reflects the updated segment organization.

  • II‐VI Laser Solutions contains the former Infrared Optics segment, the semiconductor laser portion of the former Active Optical Products segment, and smaller units of high power laser technology from the former Near-Infrared Optics segment.
  • II‐VI Photonics contains the remaining majority of the former Near-Infrared Optics segment as well as the pump laser and optical amplifier businesses of the former Active Optical Products segment.
  • II‐VI Performance Products contains the former Military & Materials and the former Advanced Products Group segments.

Segment Information

Operating income is defined as earnings before income taxes, interest expense and other expense or income, net.

Segment Bookings, Revenues and Operating Income
$ Millions, except %
(Unaudited) Three Months Ended % Increase (Decrease) from
  Sept 30, June 30, Sept 30, June 30, Sept 30,
  2014 2014 2013 2014 2013
           
Bookings:          
II-VI Laser Solutions $70.0 $82.0 $51.6 (15%) 36%
II-VI Photonics 66.3 64.1 40.6 3% 63%
II-VI Performance Products 45.4 47.2 50.3 (4%) (10%)
Total Bookings $181.7 $193.3 $142.5 (6%) 28%
           
Revenues:          
II-VI Laser Solutions $72.8 $71.5 $55.9 2% 30%
II-VI Photonics 63.6 61.2 42.0 4% 51%
II-VI Performance Products 49.4 55.2 52.1 (11%) (5%)
Total Revenues $185.8 $187.9 $150.0 (1%) 24%
           
Operating Income (Loss):          
II-VI Laser Solutions $12.9 $8.0 $8.9 61% 45%
II-VI Photonics 2.1 (0.9) 0.8 333% 163%
II-VI Performance Products 4.4 7.6 3.8 (42%) 16%
Total Operating Income $19.4 $14.7 $13.5 32% 44%

Below is a reconciliation of Operating Income reported in this press release to reported Net Earnings. 

Reconciliation of Operating Income to Net Earnings
$ Millions
(Unaudited) Three Months Ended
  Sept 30, June 30, Sept 30,
  2014 2014 2013
       
Operating Income $ 19.4 $ 14.7 $ 13.5
Interest expense 1.2 1.4 0.5
Other expense (income), net 1.7 (0.9) 0.1
Income taxes 4.2 1.5 3.2
Net Earnings $ 12.3 $ 12.7 $ 9.7

EBITDA is defined as earnings before interest, income taxes, depreciation and amortization.

Below is a reconciliation of Operating Income reported in this press release to EBITDA. 

Reconciliation of Operating Income to EBITDA
$ Millions
(Unaudited) Three Months Ended
  Sept 30, June 30, Sept 30,
  2014 2014 2013
       
Operating income $ 19.4 $ 14.7 $ 13.5
Depreciation and amortization 13.6 13.7 11.8
Other  (expense) income (1.7) 0.9 (0.1)
EBITDA $ 31.3 $ 29.3 $ 25.2

Below is a reconciliation of EBITDA reported in this press release to reported Net Earnings.

Reconciliation of EBITDA to Net Earnings
$ Millions      
(Unaudited) Three Months Ended
  Sept 30, June 30, Sept 30,
  2014 2014 2013
       
EBITDA  $ 31.3  $ 29.3  $ 25.2
Interest expense 1.2 1.4 0.5
Depreciation and amortization 13.6 13.7 11.8
Income taxes 4.2 1.5 3.2
Net Earnings  $ 12.3  $ 12.7  $ 9.7

Below is a table of other selected financial information.

Other Selected Financial Information 
$ Millions, except share information
(Unaudited) Three Months Ended
  Sept 30, June 30, Sept 30,
  2014 2014 2013
       
Cash paid for capital expenditures  $ 21.5  $ 8.4  $ 6.6
Net borrowings (payments) on indebtedness $ (5.0) $ (21.0) $ 97.0
Share-based compensation expense, pre-tax $ 3.6 $ 2.6 $ 4.1
Cash paid for shares repurchased through the Company's share repurchase programs  $ 5.1  $ 8.0 $ --
Shares repurchased through the Company's share repurchase programs 481,195 583,355 --
Average diluted shares outstanding 62,788,650 63,114,932 63,946,744

Discontinued Operations

The Company's subsidiary Pacific Rare Specialty Metals & Chemicals, Inc. ("PRM"), a business in the Company's Performance Products segment, discontinued its tellurium product line during the second fiscal quarter ended December 31, 2013. Results for all periods presented reflect the presentation of the tellurium product line as a discontinued operation.

Webcast Information

The Company will host a conference call at 9:00 a.m. Eastern Time on Tuesday, October 28, 2014 to discuss these results. The conference call will be broadcast live over the internet and can be accessed by all interested parties from the Company's web site at www.ii-vi.com as well as at http://tinyurl.com/ovx9xqx . A replay of the webcast will be available for two weeks following the call.

Use of Non-GAAP Financial Measures

The Company has disclosed adjusted financial measurements in this press release that present financial information considered to be non-GAAP financial measures. These measurements are not a substitute for GAAP measurements, although the Company's management uses these measurements as an aid in monitoring the Company's on-going financial performance. The adjusted non-GAAP net earnings and adjusted non-GAAP earnings per share measure the earnings of the Company, excluding non-recurring or unusual items that are considered by management to be outside of the Company's standard operations. There are limitations associated with the use of non-GAAP financial measures, including that such measures may not be entirely comparable to similarly titled measures used by other companies, due to potential differences among calculation methodologies. Thus, there can be no assurance that items excluded from the non-GAAP financial measures will not occur in the future, or that there could be cash costs associated with items excluded from the non-GAAP financial measures. The Company compensates for these limitations by using these non-GAAP financial measures as supplements to GAAP financial measures and by providing the reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures. Investors should consider adjusted measures in addition to, and not as a substitute for, or superior to, financial performance measures prepared in accordance with GAAP.

About II-VI Incorporated

II-VI Incorporated, a global leader in engineered materials and opto-electronic components is a vertically integrated manufacturing company that develops innovative products for diversified applications in the industrial, optical communications, military, life sciences, semiconductor equipment, and consumer markets. Headquartered in Saxonburg, Pennsylvania, with research and development, manufacturing, sales, service, and distribution facilities worldwide, the Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms including integrated with advanced software to enable our customers' success.

Forward-looking Statements

This press release contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's performance on a going-forward basis. The forward-looking statements in this press release involve risks and uncertainties, which could cause actual results, performance or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management's expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and global economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this press release include, but are not limited to: (i) the failure of any one or more of the assumptions stated above to prove to be correct; (ii) the risks relating to forward-looking statements and other "Risk Factors" discussed in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2014; (iii) the purchasing patterns from customers and end-users; (iv) the timely release of new products, and acceptance of such new products by the market; (v) the introduction of new products by competitors and other competitive responses; (vi) the Company's ability to assimilate recently acquired businesses, and risks, costs and uncertainties associated with such acquisitions; and/or (vii) the Company's ability to devise and execute strategies to respond to market conditions. The Company disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events or developments, or otherwise. 

II-VI Incorporated and Subsidiaries
Condensed Consolidated Statements of Earnings (Unaudited)
($000 except per share data)
 
  Three Months Ended
  September 30, June 30, September 30,
  2014 2014 2013
Revenues      
Net sales:      
Domestic $ 61,981 $ 61,851 $ 63,690
International 123,852 126,070 86,330
Total Revenues 185,833 187,921 150,020
       
Costs, Expenses & Other Expense (Income)      
Cost of goods sold 117,974 125,600 93,709
Internal research and development 12,943 11,322 7,747
Selling, general and administrative 35,520 36,295 35,093
Interest expense 1,204 1,415 483
Other expense (income), net 1,682 (868) 53
Total Costs, Expenses, and Other Expense (Income) 169,323 173,764 137,085
       
Earnings from Continuing Operations Before Income Taxes 16,510 14,157 12,935
       
Income Taxes 4,208 1,502 3,243
       
Earnings from Continuing Operations 12,302 12,655 9,692
       
Earnings from Discontinued Operation, net of income taxes -- -- 2
       
Net Earnings $ 12,302 $ 12,655 $ 9,694
       
Diluted Earnings Per Share:      
Continuing operations $ 0.20 $ 0.20 $ 0.15
Discontinued operation $ -- $ -- $ --
Consolidated $ 0.20 $ 0.20 $ 0.15
       
Basic Earnings Per Share:      
Continuing operations $ 0.20 $ 0.21 $ 0.16
Discontinued operation $ -- $ -- $ --
Consolidated $ 0.20 $ 0.21 $ 0.16
       
Average Shares Outstanding - Diluted 62,789 63,115 63,947
Average Shares Outstanding - Basic 61,508 61,695 62,379
 
 
II-VI Incorporated and Subsidiaries
Condensed Consolidated Balance Sheets (Unaudited)
($000)
 
  September 30, June 30,
  2014 2014
Assets    
Current Assets    
Cash and cash equivalents $ 145,415 $ 174,660
Accounts receivable 162,341 136,723
Inventories 163,421 165,873
Deferred income taxes 11,482 11,118
Prepaid and refundable income taxes 5,607 4,440
Prepaid and other current assets 14,664 12,917
Total Current Assets 502,930 505,731
Property, plant & equipment, net 207,303 208,939
Goodwill 196,023 196,145
Other intangible assets, net 133,405 136,404
Investment 11,857 11,589
Deferred income taxes 1,321 4,038
Other assets 9,246 9,080
Total Assets $ 1,062,085 $ 1,071,926
     
Liabilities and Shareholders ' Equity    
Current Liabilities    
Current portion of long-term debt $ 20,000 $ 20,000
Accounts payable 48,017 45,767
Accruals and other current liabilities 67,199 69,298
Total Current Liabilities 135,216 135,065
Long-term debt 216,733 221,960
Deferred income taxes 7,017 7,440
Other liabilities 21,278 32,418
Total Liabilities 380,244 396,883
Total Shareholders' Equity 681,841 675,043
Total Liabilities and Shareholders ' Equity $ 1,062,085 $ 1,071,926
 
 
II-VI Incorporated and Subsidiaries
Condensed Consolidated Statements of Cash Flows (Unaudited)
($000)
   
  Three Months Ended
  September 30,
  2014 2013
Cash Flows from Operating Activities    
Net cash provided by (used in):    
Continuing operations $ 856 $ 24,114
Discontinued operation -- 273
Net cash provided by operating activities 856 24,387
     
Cash Flows from Investing Activities    
Additions to property, plant and equipment (21,530) (6,573)
Payment of option to acquire business -- (5,000)
Purchases of business, net of cash acquired -- (90,601)
Net cash used in investing activities:    
Continuing operations (21,530) (102,174)
Discontinued operation -- --
Net cash used in investing activities (21,530) (102,174)
     
Cash Flows from Financing Activities    
Proceeds from borrowings -- 103,000
Payments on borrowings (5,000) (6,000)
Purchases of treasury stock (5,093) --
Payment of redeemable non-controlling interest -- (8,789)
Payments on earn-out arrangement -- (2,200)
Proceeds from exercises of stock options 1,504 2,498
Other (1,248) (1,307)
Net cash provided by financing activities (9,837) 87,202
     
Effect of exchange rate changes on cash and cash equivalents 1,266 359
     
Net (decrease) increase in cash and cash equivalents (29,245) 9,774
     
Cash and Cash Equivalents at Beginning of Period 174,660 185,433
Cash and Cash Equivalents at End of Period $ 145,415 $ 195,207
 
 
II-VI Incorporated and Subsidiaries
Reconciliation of Selected Non-GAAP Financial Measurements
($ Millions, except per share amounts)
       
Reconciliation of Reported Earnings from Continuing Operations to Non-GAAP Earnings from Continuing Operations
(Unaudited)      
       
  Three Months Ended
  Sept 30, June 30, Sept 30,
  2014 2014 2013
       
Reported Earnings from Continuing Operations  $ 12.3  $ 12.7  $ 9.7
       
Add back:      
Acquisitions transaction expenses -- -- 3.5
Write-down of selenium inventory -- -- 0.7
       
Income tax impact on unusual items -- -- (0.2)
       
Adjusted Non-GAAP Earnings from Continuing Operations  $ 12.3  $ 12.7  $ 13.7
       
Per share data:      
Earnings from Continuing Operations:      
Earnings from Continuing Operations Diluted Earnings Per Share:  $ 0.20  $ 0.20  $ 0.15
Earnings from Continuing Operations Basic Earnings Per Share:  $ 0.20  $ 0.21  $ 0.16
       
Per share, After-Tax Impact of Special Items on:      
Earnings from Continuing Operations Diluted Earnings Per Share: $ -- $ --  $ 0.06
Earnings from Continuing Operations Basic Earnings Per Share: $ -- $ --  $ 0.06
       
Adjusted Non-GAAP Earnings from Continuing Operations:      
Adjusted Non-GAAP Earnings from Continuing Operations Diluted Earnings Per Share:  $ 0.20  $ 0.20  $ 0.21
Adjusted Non-GAAP Earnings from Continuing Operations Basic Earnings Per Share  $ 0.20  $ 0.21  $ 0.22

II-VI Incorporated Mary Jane Raymond, Chief Financial Officer (724) 352-4455

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trinity's Minneapolis Move Signals Freight Momentum

Updated Category News Views 36

A suite change inside downtown Minneapolis is usually wallpaper, but this one carries a little more weight. Trinity Logistics has moved its Minneapolis team from Suite 1850 to Suite 1700 at 100 S. 5th Street, saying the larger space is needed for continued growth and future opportunity. Nobody should confuse an office relocation with a freight-cycle victory lap. Still,...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 229

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 188

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Qonto's Banking License Raises the Stakes in Europe

Updated Category News Views 56

A regulatory stamp can look dull on paper, yet this one changes the machinery underneath Qonto. The Paris-based finance platform has received a Credit Institution license from France's ACPR and the European Central Bank, giving it a route to offer broader lending and savings products directly to small and midsize businesses across Europe. That is a serious corporate...

Continue Reading
Charter’s $1.5 Billion Tender Tests Debt Discipline

Updated Category News Views 247

Debt cleanup arrives with a hard ceiling Eight far-dated bond issues just got a very specific invitation from Charter Communications: hand them over for cash, but do not expect the company to write a blank check. Charter set final pricing on November 17 for tender offers covering up to $1.5 billion in aggregate consideration, excluding accrued interest and deal expenses....

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 159

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 105

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
RayNeo's Black Friday Push Tests Smart Glasses Demand

Updated Category News Views 49

A million shipped pairs is a real milestone, but holiday markdowns are where the rubber meets the road for RayNeo. The company is taking its XR gaming glasses and iO AI smart glasses into Europe’s Black Friday scrum with discounts running through late November, betting that portability, giant virtual screens and a little AI convenience can pry open consumers’ wallets....

Continue Reading
Clorox Boosts Payout With Steady $1.25 Dividend

Updated Category News Views 205

Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 131

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading

Top 5 Most Recently Viewed Articles

Lexicon Pharmaceuticals Unveils Q3 Financials and Future Plans

Updated Category News Views 138

Third Quarter Financial Highlights of Lexicon Pharmaceuticals Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) has disclosed its financial performance for the third quarter of 2025, highlighting significant revenue increases attributed primarily to strategic licensing agreements and product sales. Strategic Partnerships and Revenue Growth In an impressive leap, Lexicon's...

Continue Reading
Growing Innovations in Robotic Dentistry to 2034 and Beyond

Updated Category News Views 178

The Rise of Robotic Dentistry and Its Market Growth The shift towards technological integration in the healthcare sector has begun a revolutionary transformation in dental care. The robotic dentistry market is anticipated to grow significantly, projected to increase from USD 617.39 million in 2024 to an approximate USD 2.24 billion by 2034. This acceleration is based on a...

Continue Reading
Chipotle Lawsuit Update: Key Actions for Shareholders

Updated Category News Views 126

Important Information for Chipotle Shareholders Shareholders of Chipotle Mexican Grill, Inc. (NYSE: CMG) are being advised about an ongoing class action lawsuit that could impact their investments. It is vital for all affected shareholders to take note of critical deadlines and actions they need to undertake to ensure their rights and potential recoveries are protected....

Continue Reading
Quisitive Technology Solutions Reports Q2 2024 Financial Results

Updated Category News Views 144

Quisitive Reports Second Quarter 2024 Financial Results Quisitive Technology Solutions Inc. (“Quisitive” or the “Company”) (TSXV: QUIS, OTCQX: QUISF), a leading provider of Microsoft Cloud and AI solutions, has announced its financial results for the second quarter ending June 30, 2024. Management Commentary Quisitive's CEO, Mike Reinhart, commented, “The first...

Continue Reading
Natural Grocers Reports Strong Fiscal 2024 Performance

Updated Category News Views 231

Natural Grocers by Vitamin Cottage Sees Remarkable Growth in Fiscal 2024 Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) has unveiled its financial results for the fourth quarter and full year of fiscal 2024. The report highlights significant sales and earnings achievements, showcasing the company’s robust performance in a competitive grocery market. Exceptional...

Continue Reading